1-5 of 5
Wei Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control

Emilio Sanseviero, Erin M. O’Brien, Jenna R. Karras, Tamer B. Shabaneh, Bulent Arman Aksoy, Wei Xu, Cathy Zheng, Xiangfan Yin, Xiaowei Xu, Giorgos C. Karakousis, Ravi K. Amaravadi, Brian Nam, Mary Jo Turk, Jeff Hammerbacher, Mark P. Rubinstein, Lynn M. Schuchter, Tara C. Mitchell, Qin Liu, Erica L. Stone
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (8): 1371–1380.
https://doi.org/10.1158/2326-6066.CIR-18-0386
Published: 01 August 2019
View article titled, Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Open the PDF for Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control in another window
Includes: Supplementary data
Journal Articles

Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation

Guan-Min Jiang, Hong-Sheng Wang, Jun Du, Wei-Feng Ma, Hui Wang, Yu Qiu, Qiu-Gui Zhang, Wei Xu, Hui-Fang Liu, Jian-Ping Liang
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (1): 42–51.
https://doi.org/10.1158/2326-6066.CIR-16-0102
Published: 03 January 2017
View article titled, Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation
Open the PDF for Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation in another window
Journal Articles

Abstract PR05: Peripheral blood immune profiling of anti-PD-1 therapy in human melanoma reveals a link between T cell re-invigoration and tumor burden that predicts response

Alexander Huang, Michael A. Postow, Robert J. Orlowski, Rosemarie Mick, Bertram Bengsch, Sasi Manne, Wei Xu, Shannon Harmon, Matthew Adamow, Deborah Kuk, Katherine Panangeas, Cristina Carerra, Phillip Wong, Felix Quagliarello, Kristen E. Pauken, Ramin S. Herati, Suzanne McGettigan, Shawn Kothari, Sangeeth M. George, Brandon Wenz, Kurt D'Andrea, Xiaowei Xu, Ravi K. Amaravadi, Giorgos Karakousis, Lynn M. Schuchter, Katherine L. Nathanson, Jedd D. Wolchok, Tara C. Gangadhar, John Wherry
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): PR05.
https://doi.org/10.1158/2326-6066.IMM2016-PR05
Published: 31 October 2016
View article titled, Abstract PR05: Peripheral blood immune profiling of anti-PD-1 therapy in human melanoma reveals a link between T cell re-invigoration and tumor burden that predicts response
Journal Articles

Abstract A036: Anti-PD1 therapy and CD8 T cell invigoration in metastatic melanoma

Alexander Huang, Wei Xu, Shannon Harmon, Felix Quagliarello, Ramin Herati, Kristen Pauken, Bertram Bengsch, Lynn Schuchter, Ravi Amaravadi, Suzanne McGettigan, Tara Gangadhar, John Wherry
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A036.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A036
Published: 03 January 2016
View article titled, Abstract A036: Anti-PD1 therapy and CD8 T cell invigoration in metastatic melanoma
Journal Articles

IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model

Rishi Surana, Shangzi Wang, Wei Xu, Sandra A. Jablonski, Louis M. Weiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (11): 1103–1112.
https://doi.org/10.1158/2326-6066.CIR-14-0103
Published: 02 November 2014
View article titled, IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model
Open the PDF for IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model in another window
Includes: Supplementary data